ABSTRACT Infusion of dipyridamole has been suggested as an alternative to exercise stress for myocardial perfusion imaging for detection of ischemia, but the mechanism and significance of thallium-201 (201T1) Hg), but an unchanged total coronary flow (53 ± 8 to 52 8 ml/min; p = NS) and stenosis gradient, and hence, stenosis resistance. Although transmural flow was unaltered in the stenotic region after dipyridamole, epicardial flow increased from 1.00 0.18 to 1.27 ± 0.47 ml/min/g and endocardial flow fell from 0.65 + 0.15 to 0.50 ± 0.22 ml/min/g, resulting in an endocardial/epicardial flow gradient. In the range of transmural flow values between 0. 10 and 1 .4 ml/min/g, the intrinsic 20 Tl washout rate became more prolonged as flow decreased. Thus, in the presence of a critical coronary stenosis, the dipyridamole-induced fall in systemic arterial pressure and distal coronary perfusion caused a subnormal endocardial blood flow and ischemia, resulting in a prolonged intrinsic myocardial 201T1 efflux rate. The disparate 201T1 efflux rates in normal and underperfused myocardium can explain delayed redistribution observed after dipyridamole infusion in the presence of a coronary stenosis. Circulation 71, No. 2, 378-386, 1985. MYOCARDIAL perfusion imaging has been performed during coronary vasodilation produced by intravenously administered dipyridamole both for detecting coronary artery disease"'2 and for identifying high-risk patients after myocardial infarction.'3 This potent coronary vasodilator enhances regional myocardial blood flow in zones supplied by normal coronary arteries but not in myocardium perfused by obstructed vessels, resulting in flow inhomogeneity. Since 
MYOCARDIAL perfusion imaging has been performed during coronary vasodilation produced by intravenously administered dipyridamole both for detecting coronary artery disease"'2 and for identifying high-risk patients after myocardial infarction.'3 This potent coronary vasodilator enhances regional myocardial blood flow in zones supplied by normal coronary arteries but not in myocardium perfused by obstructed vessels, resulting in flow inhomogeneity. Since the initial myocardial distribution of intravenously administered thallium-201 (20'Tl) is proportional to blood flow, '4 15 scintigraphic defects are observed that demonstrate this relative hypoperfusion. Wel6 and others 12, 17. 1 have demonstrated that under conditions of a coronary stenosis in canine preparations of ischemia or in humans, dipyridamole-or adenosine-induced vasodilation results not only in diminished 201T1 uptake but also in subsequently delayed redistribution similar to that observed with exercise scintigraphy. Redistribution defects have also been demonstrated on serial myocardial scintigrams in patients with coronary artery disease receiving dipyridamole before administration of 201T1. 8 The mechanism and significance of 201T1 redistribution after dipyridamole imaging are uncertain. Total blood flow in a stenotic vessel is not decreased after intravenous infusion of dipyridamole.'6 Furthermore, myocardial oxygen demand is not increased in response to the drug. The duration of active vasodilation may be more prolonged than that induced by exercise. Dipyridamole as well as adenosine are known to produce a significant endocardial-to-epicardial flow gradient distal to a coronary stenosis. [19] [20] [21] [22] [23] [24] [25] [26] [27] This may produce regions of subendocardial ischemia adjacent to regions of normal or even enhanced epicardial flow.
In an earlier study of serial myocardial needle biopsy specimens from anesthetized dogs with a critical left anterior descending coronary stenosis,16 we showed that when 201T1 was injected intravenously after infusion of dipyridamole, net clearance of 20l1T1 from the region of stenosis was slower than that from normal myocardium. The difference in net clearance rates resulted in normalization of the initial defect (redistribution). This could be the result of altered delivery of the tracer to the myocardium (blood flow), of altered extraction of the tracer by the myocardium, or of alterations in the intrinsic efflux of 201T1 from the myocardium. It is not possible to infer the mechanism of redistribution after intravenous injection of the tracer in an intact animal because only the net effect of continuous exchange and recirculation can be observed in such a preparation. The intracellular efflux of 20'T1 can be investigated by using intracoronary rather than intravenous injections of the radionuclide.8 This method effectively eliminates systemic recirculation of 201T1 and allows the determination of intrinsic cellular efflux rates. These rates can then be combined with the values of net myocardial clearance to more completely define the mechanism of thallium uptake and washout in the closed system in the presence of systemic recirculation.
Accordingly, the purpose of these experiments was to measure the intrinsic 201T1 washout rates and alterations in regional blood flow during dipyridamoleinduced vasodilation. Disparate efflux rates of 201TI in normal and relatively underperfused myocardial regions in response to the drug could explain the delayed 201T1 redistribution that is seen when the radionuclide is administered intravenously under similar hemodynamic and regional flow conditions.
Methods
Canine preparation. These studies were undertaken in mongrel dogs weighing from 20 to 30 kg. The dogs fasted for 24 hr before surgery and were anesthetized with pentobarbital sodium at a dose of 30 mg/kg iv. After intubation the dogs were ventilated on a Harvard Apparatus respirator at a rate of 1 3/min with a tidal volume of approximately 500 cc. The respirator frequency and tidal volume were adjusted according to arterial blood gas measurements monitored serially. Throughout the experiments, small additional doses of pentobarbital were given periodically. The electrocardiogram was monitored continuously, with 18-gauge stainless steel needles inserted subcutaneously as leads. An intramedic No. 7450 femoral vein catheter was inserted for administration of intravenous fluid. The animals were given 5% dextrose/0.9% normal saline solution infused at a rate sufficient to maintain the left atrial filling pressure and arterial blood pressure at stable levels during the control period of the experiment. Usually, left atrial pressure ranged between 3 and 5 mm Hg.
Catheters were introduced into both femoral arteries and advanced to the central aorta via cutdowns over the vessels. One of these catheters was used to constantly measure arterial blood pressure and both were used to withdraw simultaneous reference blood samples for regional blood flow determination by the microsphere technique.
After instrumentation was completed, the left thoracotomy was performed and the heart was appropriately exposed for coronary dissection. The proximal portion of the left anterior descending or left circumflex coronary artery was then dissected free of the epicardium and a hydraulic occluder (Rhodes Medical Instruments, Model VO-3) was placed around either vessel. An appropriately sized electromagnetic flow probe (Carolina Instruments) was fitted proximal to the occluder in each animal. Another snare was placed distal to the flow probe and occluder and was used for making the 10 sec transient occlusions for determination of the reactive hyperemic responses. A small 22-gauge angiocatheter (Desseret) was inserted to a distal branch of the coronary vessel and connected to a Hewlett-Packard 1280 pressure transducer for continuous monitoring of distal coronary perfusion pressure throughout the study. Finally, a flared polyethylene catheter was inserted via a stab wound into the left atrial appendage and was used for both pressure measurements and for injection of radioactively labeled microspheres.
Regional blood flow measurements. Regional myocardial blood flow was determined by the radioactive microsphere technique. 29 Microspheres labeled with 46Sc (10.9 + 0.3 gm), 95Nb (10.9 + 0.3 ,um), and 103Ru (11.0 ± 0.3 ,um) were obtained from New England Nuclear Corp. and an aliquot containing 2 x 106 spheres was calibrated for bolus injection. Each dose of spheres was first diluted to a volume of 5 ml with normal saline containing 0.0 1% polysorbate 80 (Tween 80) to prevent clumping. Before injection, the spheres were agitated vigorously by injecting them back and forth between two 6 ml syringes connected by a stopcock. Microscopic examination of a drop of this suspension demonstrated no aggregation or clumping. Similarly, duplicate reference arterial samples drawn simultaneously were comparable in counts per milliliter per minute. This implied adequate dispersion of spheres.
The microsphere suspensions were injected as a bolus over 5 to 10 sec into the left atrium after which the injection catheter was flushed with 3 to 5 ml of 0.9% saline with constant monitoring of arterial blood pressure, electromagnetic flow, coronary perfusion pressure, and heart rate. This procedure was repeated for the microsphere dose administered at the peak effect of dipyridamole. Duplicate time withdrawals from the two femoral artery catheters were begun 10 to 15 sec before microsphere injection and continued for a total of 90 sec. Blood samples from each femoral withdrawal were divided among three to four tared tubes. At the end of the experiment the animal was killed and the left ventricle and septum were separated from the remainder of the heart, which was trimmed of epicardial fat and blood vessels and divided into four distinct transfer sections from apex to base. Each of these sections was then cut into eight transmural segments and each segment was further subdivided Vol. 71, No. 2, February 1985 into epicardial, midwall, and endocardial layers. The resulting 95 specimens were weighed and counted together with the duplicate femoral arterial withdrawals and pure isotope samples for 500 sec in a Packard Gamma Auto Scintillation counter. A multichannel analyzer was used for separation of isotope peaks with the following windows: 46Sc = 740 to 1300 keV, 95Nb -650 to 1818 keV, '03Ru = 450 to 570 keV.
Myocardial blood flow was calculated with the equation Qm -(Cm x 100 Qr)/Cr, where Qm = myocardial blood flow (ml/min), Cm = tissue counts (counts/min), Qr = withdrawal rate of the arterial samples (ml/min), and Cr = counts in the reference arterial sample. Flow per gram of myocardium was calculated by dividing blood flow by sample weight. Isotope separation and myocardial blood flow values were calculated according to methods previously described. 16 All myocardial samples were held 2 weeks before counting to permit decay of 201T1 activity to more appropriate levels. The counts per minutes recorded in each window for myocardial and reference blood samples were corrected for background activity as well as spill activity contributed by the isotopes of higher energy. Standard deviations for the regional myocardial flow values were obtained from the variance computed from counting multiple samples and reflects local inhomogeneity of microsphere deposition or actual flow inhomogeneity. Individual samples typically provided 50,000 counts; therefore, the Poisson statistic was comparatively small and could be considered a minor contribution to the overall sample variance. The individual Poisson error of approximately 0.5% when propagated through the matrix increased to no more than 1% to 2%.
Measurement of intrinsic 201T1 washout rate. The intrinsic washout rate of 201T1 was determined after direct intracoronary injection of the radiotracer as previously described.28 By this mode of administration there is almost no systemic recirculation of thallium back to the myocardium, thus permitting assessment of the true efflux rate of 201T1 from myocardium into the systemic pool. An external collimated gamma-detector probe was positioned over the heart above the epicardial surface. After intracoronary 201T1 administration, radionuclide counts were recorded and printed every 30 sec by interfacing the gamma probe with a scaler timer and digital recorder. The 201T1 washout rates thus were obtained by a least-squares curve fitting a monoexponential to obtain the clearance coefficient, K, and deriving tl/2 = 0.693/K. Previously, we have shown that the intrinsic washout rates calculated by this method correlate well with the intrinsic washout rate calculated under the same experimental conditions with serial coronary sinus samples used for measuring 201T1 efflux from the myocardium.25
Experimental protocol. Six normal dogs served as a control group. A dose of 50,uCi of 201T1 was injected directly into either the left anterior descending or left circumflex coronary artery, after which myocardial 201TI counts were measured every 30 sec for 15 min with the gamma probe. The first set of radioactive microspheres was also injected into the left atrium as described previously. After baseline pressures were recorded and washout and flow measurements were obtained, a dose of 0.15 (n = 5) or 0.25 (n = 13) mg/kg dipyridamole was infused intravenously over a period of 1 min, after which 201Tl isotopic activity was again recorded for 15 min over the same myocardial region. The second set of microspheres was then injected at 4 min after administration of dipyridamole.
In another 12 dogs receiving 50,uCi of 20MT1 via the intracoronary route, a critical coronary stenosis was produced after baseline hemodynamic and 201T1 washout measurements were obtained. For the purpose of these experiments, a critical stenosis was defined as a partial narrowing of the coronary lumen with the hydraulic occluder that nearly or totally ablated the reactive hyeremic response to a transient 10 sec occlusion. 201T1 washout was again measured with the stenosis in place, and radioactive microspheres were injected into the left atrium. Figure 2 illustrates changes in mean epicardial and endocardial blood flows in the myocardial region from which 201TI washout values were obtained. As expected, dipyridamole infusion resulted in significant increases in epicardial (0.95 ± 0.11 to 2.23 ± 0.46 ml/ min/g; p = .01) and endocardial (0.86 ± 0.10 to 1.53 ± 0.27; p = .029) flows. Transmural flow, which was the average of inner (subendocardial), middle, and outer (subepicardial) sample flow values, rose from 1.04 + 0.09 to 2.13 ± 0.51 ml/min/g after dipyridamole infusion.
Thus, in normal dogs dipyridamole-induced coronary vasodilation resulted in a more rapid intrinsic myocardial washout rate of 201T1 coincident with increases in both epicardial and endocardial blood flow.
Stenosis group. The changes in the mean 201TI intrinsic washout rate after the production of a coronary stenosis and after dipyridamole infusion in the presence of this stenosis for the 12 dogs in the stenosis group are shown in figure 3 . Before the coronary occluder was inflated, the tl/2 for intrinsic 201TI washout was 70 ± after production of the stenosis. After dipyridamole infusion the intrinsic 201T1 washout slowed further to 169 ± 21 min (p = .003). Figure 4 shows the changes in the t½ /2of intrinsic 207T1 washout in one of the dogs with a critical stenosis receiving dipyridamole after intracoronary 207T1 administration. The tl/2 for 201T1 :> washout was slowed during occlusion (102 min) compared with the preocclusion state (51 min) and was slowed even further after dipyridamole (153 min). This response was contrary to that observed when the drug was given to control animals with totally patent coronary arteries in which the intrinsic 201T1 washout became more rapid. There was no significant change in mean heart rate (beats/min) from control (133 ± 8) to stenotic (135 ± 8) to postdipyridamole (139 ± 6) conditions. As shown in figure 5 , no change in mean aortic pressure occurred with production of the stenosis alone, but aortic pressure fell from 91 ± 5 to 74 + 6 mm Hg after dipyridamole infusion (p < .000 1). As also depicted in figure 5 , the coronary perfusion pressure significantly decreased from 93 + 6 to 60 + 4 mm Hg after the stenosis was established (p < .001) and decreased even further to 45 ± 3 mm Hg after dipyridamole infusion (p < .0001). Total coronary flow measured by electromagnetic probe was 72 ± 9 ml/min at baseline and fell to 53 ± 8 ml/min (p .008) after placement of the stenosis. After dipyridamole, coronary flow in the stenotic vessel was unchanged at 52 ± 8 ml/min.
Changes in epicardial and endocardial regional blood flow after dipyridamole infusion in the normal region and in the region perfused by the coronary stenosis are summarized in figure 6 . Under basal conditions with the coronary stenosis in place, the stenosis alone resulted in a lower baseline endocardial flow in the stenotic region (0.65 ± 0. 15 ml/min/g) compared with the normal region (1.22 ± 0.16 ml/min/g; p , respectively) to a degree comparable to that observed in the six control dogs. In contrast, in the stenotic region there was a slight increase in epicardial flow (1.00 ± 0. 18 to 1.27 ± 0.47 ml/min/g) but an actual fall in endocardial flow (0.65 ± 0.15 to 0.50 ± 0.22 ml/min/g) after dipyridamole infusion. Although these changes were not statistically significant, there appears to be evidence of an endocardial-to-epicardial "steal" phenomenon in the stenotic region at peak vasodilation. Transmural flow derived from the average flow in the inner, middle, and outer layers was 1.20 ± 0.12 ml/min/g at baseline and decreased to 0.81 ± 0.14 ml/min/g after the stenosis was placed. With dipyridamole infusion transmural flow was unchanged at 0.87 ± 0.34 ml/min/g. Since coronary flow and the pressure gradient across the stenosis were unchanged after dipyridamole, the stenosis resistance did not change. This is important because it demonstrates that dipyridamole infusion does not cause passive collapse of the stenosis as aortic and distal coronary pressures fall.
The relationship between transmural myocardial blood flow and the t/2 for the intrinsic washout rate of thallium is plotted in figure 7 . The points shown on the 
Discussion
In these experiments the effect of dipyridamole was to increase myocardial capillary blood flow to approximately 2 to 2½/2 times its baseline value in normal regions supplied by a patent coronary artery. When a critical stenosis was in place on a coronary artery, the infusion of dipyridamole produced no significant change in the total flow as measured by the electromagnetic flowmeter through the The intrinsic thallium washout rate was measured by external counting of the intact myocardium and would have to be considered a transmural sample. When there is a gradient of flow between the epicardium and endocardium, the washout rate determined from the probe data will represent the integration of this continuum and the washout coefficient must be considered a lumped constant. The washout rate obtained from these samples as a function of transmural capillary blood flow is illustrated in figure 7 . For above-normal blood flow values of approximately 1.4 ml/min/g, the intrinsic efflux half-time is nearly constant and hence independent of blood flow. This would appear to be a regime in which thallium efflux is rate-limited by its diffusion across the cell membrane and thus becomes flow independent.
At subnormal myocardial blood flow levels the intrinsic efflux half-time becomes sharply prolonged. This could be the result of diminished active transport by ischemic myocardial cells. It could also be the result of slower clearing of the interstitial space and cellular reuptake when capillary blood flow is diminished. The prolonged intrinsic efflux may also be the result of partial capillary closure where thallium already extracted is "trapped" and will have a lengthened diffusion path to reach the blood compartment.
Although all three of the above mechanisms for delayed thalium efflux when blood flow is reduced may be simultaneously at work, the latter mechanism involving partial capillary closure is consistent with the observation that the endocardium may be near or at the level of capillary closure at the level of coronary pressures measured distal to the critical stenosis after the administration of dipyridamole (figure 8). We have demonstrated an almost equivalent phenomenon in a previous series of experiments28 by measuring the intrinsic myocardial thallium efflux rate after production of graded stenoses in the absence of dipyridamole. It was shown that the intrinsic thallium efflux approaches an almost asymptotic rise when the pressure in the coronary supply artery falls to about 30 mm Hg. This, combined with the present data showing that endocardial blood flow drops essentially to zero at about the same pressure, suggests a stop-flow phenomenon that appears at the same coronary arterial pressure regardless of whether the pressure decrease was caused by graded stenosis or by the infusion of dipyridamole.
The main effect of dipyridamole may have been the reduction of mean arterial (aortic) pressure in the presence of a critical stenosis. In this setting the pressure gradient across the stenosis before dipyridamole was significant but perfusion pressure distal to the stenosis was still adequate to maintain near-normal transmural blood flow. The vasodilatory effects of dipyridamole diminish over time after injection. As subendocardial flow in the stenotic region gradually increases with a rise in coronary perfusion pressure, an increase in 201T1 delivery to this previously ischemic layer will occur via recirculation of the radionuclide and will contribute to delayed redistribution even if aminophylline is not administered.
There are several clinical implications of this study. Leppo et al. ' 3 recently reported that presence of 20IT1 redistribution on a predischarge 201TI dipyridamole scintigram is a sensitive predictor of future cardiac events. Leppo et al.8 also reported that myocardial segments showing initial defects with subsequent redistribution after dipyridamole usually demonstrate preserved resting wall motion, and persistent defects are usually associated with akinetic myocardial segments, similar to what has been observed with exercise
